Shanghai Pharmaceuticals Holding Co (HKSE:02607) Ending Cash Position : HK$29,467 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Ending Cash Position?

Shanghai Pharmaceuticals Holding Co's Ending Cash Position for the quarter that ended in Mar. 2024 was HK$29,467 Mil.

Shanghai Pharmaceuticals Holding Co's quarterly Ending Cash Position increased from Sep. 2023 (HK$28,504 Mil) to Dec. 2023 (HK$30,079 Mil) but then declined from Dec. 2023 (HK$30,079 Mil) to Mar. 2024 (HK$29,467 Mil).

Shanghai Pharmaceuticals Holding Co's annual Ending Cash Position increased from Dec. 2021 (HK$24,658 Mil) to Dec. 2022 (HK$27,397 Mil) and increased from Dec. 2022 (HK$27,397 Mil) to Dec. 2023 (HK$30,079 Mil).

Shanghai Pharmaceuticals Holding Co Ending Cash Position Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Ending Cash Position Chart

Shanghai Pharmaceuticals Holding Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

17,488.28

23,206.56

24,657.71

27,397.36

30,078.71

Shanghai Pharmaceuticals Holding Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															27,455.17	31,378.74	28,503.84	30,078.71	29,466.94

Shanghai Pharmaceuticals Holding Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Shanghai Pharmaceuticals Holding Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	26834.651	+	3244.059
	=	30,079

Shanghai Pharmaceuticals Holding Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	29873.083	+	-406.144
	=	29,467

Shanghai Pharmaceuticals Holding Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (HKSE:02607) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

SHPMY:USA SHPMF:USA S1R:Germany 601607:China

Address

No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020

Website

https://www.sphchina.com

Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.

Executives

Blackrock, Inc.	2201 Interest of corporation controlled by you
Shanghai Industrial Investment (holdings) Company Limited	2201 Interest of corporation controlled by you
Siic International Investment Company Limited	2101 Beneficial owner
Citigroup Inc.	2201 Interest of corporation controlled by you
Lsv Asset Management	2102 Investment manager

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Headlines

No Headlines